Image
 

November 2021

Old Cancer Drug May Have New Purpose: Treating Chronic Pain

 

Over the years, several drugs that were developed to treat medical conditions such as epilepsy and depression have been repurposed as treatments for chronic pain. Pregabalin (Lyrica) and duloxetine (Cymbalta) are just two examples.


Another drug that used to be used for cancer, named kenpaullone, inhibits neurotransmission by activating a gene called Kcc2. When Kcc2 is enhanced, it reduces chloride levels in nerve cells and silences pain signals.


Read more.

Alternate text
 

Connection is Key: Michael Wright’s Support for Peripheral Neuropathy

 

Michael Wright, a neuropathy patient, proud supporter of the Foundation for Peripheral Neuropathy, and leader of the support group on Facebook, “Peripheral Neuropathy Success Stories!” was recently interviewed by the American Neuromuscular Foundation.


Read interview.

 

Exploring the Link Between Gut and Brain Health

 

Scientists continue to find evidence that the brain and gastrointestinal tract are closely linked—and that keeping one healthy will benefit the other. Aligning with this article from Brain&Life Magazine, FPN too encourages its patients to continue to live a healthy lifestyle to better manage their health and neuropathy.

 

Read more.

Alternate text
 

Insomnia and Pain: A Chronic Cycle

 

Anyone can experience a sleepless night once in a while, but if you regularly have trouble falling asleep, staying asleep, or don’t feel rested in the morning—and you also live with pain—you may be experiencing a double setback.


Learn more about the pain and insomnia connection in this article from Practical Pain Management.

Alternate text
 

Unproven Stem Cell Interventions!

 

Following our recent educational program on Biomedical Research, presented by Kristy Townsend, PhD, on November 3, where we mentioned that stem cells have still not been a proven treatment option for peripheral neuropathy patients, we came across an alarming article about unproven stem cell interventions being sold by U.S. unlicensed businesses.


All the more reason to be careful about all treatment options, but especially those that have not yet been proven to work in the field of neuropathy.


Read more.

 
 
Alternate text
 

The Foundation for Peripheral Neuropathy provides education and support today

as we walk toward a cure for tomorrow.


Support us in advancing a cure!


FPN is a non-profit organization that is solely funded by our readers.


Donate Now!

Send this to a friend